October 12, 2012 — At RSNA 2012, Philips Women’s Healthcare will launch the next generation of MicroDose with Single-Shot Spectral Imaging (SI) together with the first clinical application — Spectral Breast Density Measurement. Neither have FDA clearance yet, but will be previewed for the first time in the United States at RSNA.
New Philips MicroDose SI, a full-field digital mammography system, brings the potential of non-invasive spectral imaging to clinical practice without exposing women to additional examinations or X-ray radiation.
As with existing MicroDose systems, MicroDose SI uses direct, digital photon-counting technology. This unique technology has created a paradigm shift in mammography, allowing high-dose efficiency at low radiation dose — without compromising image quality.
With this new application, accurate spectral breast density measurements for refined risk assessments can be obtained in the same examination as a standard low-dose mammogram.
Philips will continue to work closely with clinical partners to further explore the potential of non-invasive spectral imaging to revolutionize mammography screening.
For more information: www.philips.com
July 31, 2026 
